Grantham, Mayo, Van Otterloo & Co (GMO)’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.22M Buy
10,345
+1,200
+13% +$148K ﹤0.01% 489
2025
Q4
$1.15M Buy
9,145
+1,335
+17% +$174K ﹤0.01% 497
2025
Q3
$1.14M Buy
7,810
+1,010
+15% +$153K ﹤0.01% 465
2025
Q2
$1.06M Buy
6,800
+2,500
+58% +$396K ﹤0.01% 473
2025
Q1
$708K Buy
+4,300
New +$715K ﹤0.01% 494

Other funds holding ZTS

Grantham, Mayo, Van Otterloo & Co (GMO)'s ZTS Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Zoetis (ZTS) stake by 13% in Q1 2026, buying an estimated $148K and bringing the position to 10,345 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #489.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ZTS in Q1 2025 and has held it in 5 quarters since. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 10,345 shares of Zoetis worth $1.22M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 1,200 Zoetis shares in Q1 2026, an estimated $148K.
  • Zoetis made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #489 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Zoetis in Q1 2025 and has held it in 5 quarters since.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.